Jeff Farrow's guest appearances

Jeff Farrow

CFO THOUGHT LEADER

Marc Elliot

Sachin Patel

Lawrence Levy

Rajesh Gupta

Dave Jones

Jeff Epstein

John Collins

Eric Johnson

Michael Tannenbaum

Kraft Heinz

Chris Baker

Bob Feller

Dave Kellogg

Jeff Nichols

Jim Stewart

OwlTail

An Early Dose of Pharma Start-Up Experience When Global Blood Therapeutics CFO Jeffrey Farrow says he took the corporate-finance career path less traveled, he really means it. As an undergraduate biology major, Farrow and a couple of entrepreneurial-minded postdocs hit upon a way to identify a protein thought to cause Alzheimer’s. The group licensed the technology from the University of California system and launched their own company, “which we naively thought we maybe could take public,” Farrow recounts. He and his co-founders instead wound up selling their venture to a larger neuroscience company. The experience helped Farrow, who managed the startup’s business side, shed his naiveté via a potent dose of real-world experience. After a stint in public accounting, Farrow returned to the pharmaceutical industry where he’s subsequently taken on numerous CFO and finance executive positions while leading IPOs, shepherding high-growth companies toward (and through) acquisitions, and guiding early-stage pharma companies through the regulatory approval process and commercial launch of new drugs.

<p>An Early Dose of Pharma Start-Up Experience</p> <p>When Global Blood Therapeutics CFO Jeffrey Farrow says he took the corporate-finance career path less traveled, he really means it. As an undergraduate biology major, Farrow and a couple of entrepreneurial-minded postdocs hit upon a way to identify a protein thought to cause Alzheimer’s. The group licensed the technology from the University of California system and launched their own company, “which we naively thought we maybe could take public,” Farrow recounts. He and his co-founders instead wound up selling their venture to a larger neuroscience company. The experience helped Farrow, who managed the startup’s business side, shed his naiveté via a potent dose of real-world experience. After a stint in public accounting, Farrow returned to the pharmaceutical industry where he’s subsequently taken on numerous CFO and finance executive positions while leading IPOs, shepherding high-growth companies toward (and through) acquisitions, and guiding early-stage pharma companies through the regulatory approval process and commercial launch of new drugs.</p>

466:  Energizing the Realm of  Early Stage Pharma | Jeff Farrow, CFO, Global Blood Therapeutics